ID

14481

Beskrivning

Study Comparing 3 Dosage Levels Of SAM-531 In Outpatients With Mild To Moderate Alzheimer Disease; ODM derived from: https://clinicaltrials.gov/show/NCT00895895

Länk

https://clinicaltrials.gov/show/NCT00895895

Nyckelord

  1. 2016-04-17 2016-04-17 -
Uppladdad den

17 april 2016

DOI

För en begäran logga in.

Licens

Creative Commons BY 4.0

Modellkommentarer :

Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.

Itemgroup-kommentar för :

Item-kommentar för :

Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.

Eligibility Alzheimer Disease NCT00895895

Eligibility Alzheimer Disease NCT00895895

Inclusion Criteria
Beskrivning

Inclusion Criteria

Alias
UMLS CUI
C1512693
diagnosis of probable alzheimer disease according to the national institute of neurological and communicative disorders and stroke-alzheimer's diseases and related disorders association (nincds-adrda) criteria.
Beskrivning

alzheimers disease; NINCDS-ADRDA Criteria

Datatyp

boolean

Alias
UMLS CUI [1]
C0002395
UMLS CUI [2]
C2828081
mini-mental state examination (mmse) score of 12 to 24 at screening
Beskrivning

mini-mental state examination

Datatyp

boolean

Alias
UMLS CUI [1]
C0451306
rosen modified hachinski ischemic score < or equal to 4 at screening.
Beskrivning

Modified Hachinski Ischemic Scale

Datatyp

boolean

Alias
UMLS CUI [1]
C3826978
Exclusion Criteria
Beskrivning

Exclusion Criteria

Alias
UMLS CUI
C0680251
relevant neurologic disease other than alzheimer disease that may affect cognition or ability to complete the study.
Beskrivning

neurologic disease

Datatyp

boolean

Alias
UMLS CUI [1]
C0027765
current major depressive disorder or other current major psychiatric disorder.
Beskrivning

depressive disorder; psychiatric disorder

Datatyp

boolean

Alias
UMLS CUI [1]
C0011581
UMLS CUI [2]
C0004936
history of clinically evident stroke or clinically important carotid or vertebrobasilar stenosis or plaque.
Beskrivning

stroke; Carotid Stenosis; vertebrobasilar stenosis; plaque

Datatyp

boolean

Alias
UMLS CUI [1]
C0038454
UMLS CUI [2]
C0007282
UMLS CUI [3]
C0149810
UMLS CUI [4]
C0332461
use of prescription or nonprescription medications for cognitive enhancement (including memantine, ginkgo biloba, huperzine a, and cholinesterase inhibitors) within 3 months before the baseline visit.
Beskrivning

memantine; Ginkgo biloba; huperzine a; cholinesterase inhibitors

Datatyp

boolean

Alias
UMLS CUI [1]
C0025242
UMLS CUI [2]
C0330206
UMLS CUI [3]
C0063033
UMLS CUI [4]
C0008425

Similar models

Eligibility Alzheimer Disease NCT00895895

Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Item Group
C1512693 (UMLS CUI)
alzheimers disease; NINCDS-ADRDA Criteria
Item
diagnosis of probable alzheimer disease according to the national institute of neurological and communicative disorders and stroke-alzheimer's diseases and related disorders association (nincds-adrda) criteria.
boolean
C0002395 (UMLS CUI [1])
C2828081 (UMLS CUI [2])
mini-mental state examination
Item
mini-mental state examination (mmse) score of 12 to 24 at screening
boolean
C0451306 (UMLS CUI [1])
Modified Hachinski Ischemic Scale
Item
rosen modified hachinski ischemic score < or equal to 4 at screening.
boolean
C3826978 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
neurologic disease
Item
relevant neurologic disease other than alzheimer disease that may affect cognition or ability to complete the study.
boolean
C0027765 (UMLS CUI [1])
depressive disorder; psychiatric disorder
Item
current major depressive disorder or other current major psychiatric disorder.
boolean
C0011581 (UMLS CUI [1])
C0004936 (UMLS CUI [2])
stroke; Carotid Stenosis; vertebrobasilar stenosis; plaque
Item
history of clinically evident stroke or clinically important carotid or vertebrobasilar stenosis or plaque.
boolean
C0038454 (UMLS CUI [1])
C0007282 (UMLS CUI [2])
C0149810 (UMLS CUI [3])
C0332461 (UMLS CUI [4])
memantine; Ginkgo biloba; huperzine a; cholinesterase inhibitors
Item
use of prescription or nonprescription medications for cognitive enhancement (including memantine, ginkgo biloba, huperzine a, and cholinesterase inhibitors) within 3 months before the baseline visit.
boolean
C0025242 (UMLS CUI [1])
C0330206 (UMLS CUI [2])
C0063033 (UMLS CUI [3])
C0008425 (UMLS CUI [4])

Använd detta formulär för feedback, frågor och förslag på förbättringar.

Fält markerade med * är obligatoriska.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial